ACTINOGEN MEDICAL LIMITED (ACW)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
ACW - ACTINOGEN MEDICAL LIMITED
FNArena Sector :
Pharmaceuticals & Biotech/Lifesciences
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: -0.01
Index:
FNArena Sector : Pharmaceuticals & Biotech/Lifesciences
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: -0.01
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.02
19 Jun |
0.000 OPEN $0.02 |
0.000 HIGH $0.02 |
2,327,994 LOW $0.02 |
| OTHER COMPANIES IN THE SAME SECTOR | |||
| 1AD . ACR . ADO . AFP . AGH . AGN . ARX . AVH . BIO . BOT . CSL . CUV . DXB . EOF . GSS . HXL . IDT . IMM . IMU . IVX . LGP . MAP . MSB . MVP . MYX . NEU . NUZ . NXS . OCC . OPT . OSL . PAR . PER . PNV . PYC . RAC . RCE . SNT . SPL . TLX . TRP . VIT . ZNO . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -0.6 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 0.0 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 0.7 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -17.0 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | - |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -78.81 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -78.20 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -71.44 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -78.81 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -138.39 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -17.0 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 9 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 8.45 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 0.0 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | - |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 0 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 23 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | 16 M |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
ACW STOCK CHART
FNArena News on ACW
Latest Pharmaceuticals & Biotech/Lifesciences News
| 1 |
CSL: Buy Trigger AheadApr 26 2022 - Technicals |
| 2 |
Why CSL Fell Sharply YesterdayDec 17 2021 - Australia |
| 3 |
Beating The Biotech BluesSep 14 2021 - International |
| 4 |
Uncertainty Prevails For CSLAug 19 2021 - Australia |
| 5 |
Flying High – Medicinal Marijuana In AustraliaJul 26 2021 - Australia |
| 6 |
Wesfarmers On Drugs?Jul 13 2021 - Australia |
| 7 |
Is CSL’s Plasma Recovery Now Priced In?Jun 23 2021 - Australia |
| 8 |
CSL: Buy The DipJun 22 2021 - Technicals |
| 9 |
CSL To Retest Its High?May 25 2021 - Technicals |
| 10 |
Treasure Chest: CSL Plasma At Turning Point?May 05 2021 - Treasure Chest |